Table 1.
Characteristic | Pre-treatment patients N = 11 n(%) | Post-treatment patients N = 15 n(%) |
---|---|---|
N = 11 | N = 15 | |
n(%) | n(%) | |
Age: median (IQR) | 62 (56–64) | 64 (60–66.5) |
Sex | ||
Female | 3 (27) | 2 (13) |
Male | 8 (73) | 13 (87) |
Race/ethnicity | ||
Caucasian/non-Hispanic | 11 (10 0) | |
Marital status | ||
Married/ Partnered | 10 (91) | 14 (93) |
Divorced | 0 (0) | 1 (7) |
Single/never married | 1 (9) | 0 (0) |
“How difficult is it for you to meet the monthly payments on your family’s bills?” | ||
Not at all difficult | 9 (82) | |
A little difficult | 1 (9) | |
Prefer not to answer | 1 (9) | |
Employment status | ||
Employed | 5 (55) | |
Disabled and not working | 1 (0) | |
Retired and not working | 4 (36) | |
Highest level of education attained | ||
High school diploma | 2 (18) | |
College degree | 3 (27) | |
University graduate degree | 6 (54) | |
AJCC 7th ed. overall stagea | ||
I–II | 1 (9) | 1(7) |
III–IV | 10 (91) | 12 (80) |
Unknown | 0 | 2 (13) |
HPV tumor status | ||
Positive | 10 (91) | 15 (100) |
Negative | 1 (9) | 0 (0) |
Primary treatment | ||
CRT | 8 (73) | 9 (60) |
Surgery | 1 (9) | 0 (0) |
Surgery + RT | 1 (9) | 5 (33) |
Surgery + CRT | 1 (9) | 1 (7) |
Months after treatment end: median (IQR) | 30 (19.5–36.5) |
Empty cells denote data were not collected or do not apply.
Abbreviations: IQR, interquartile range; AJCC, American Joint Committee on Cancer; Ed, Edition; RT, radiotherapy; CRT, chemoradiotherapy
According to AJCC 8th edition overall staging, pre-treatment group included 10 stage 1 (91%) and 1 stage II (9%).